We provide mechanistic data indicating that HuR-mediated post-transcriptional inhibition is a major component of the cellular response to DHTS and that its relevance is shown by the HuR dosage modulation of cytotoxicity and migratory potential in breast cancer cells in response to DHTS. Here, ELAVL1 is linked to breast carcinoma.